Levonadifloxacin

(S)-nadifloxacin is a nadifloxacin. It is an enantiomer of a (R)-nadifloxacin. Levonadifloxacin is under investigation in clinical trial NCT03405064 (Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)). It is grouped under the following drug class(es): Fluoroquinolones, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as antibacterials. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include levonadifloxacino and levonadifloxacinum. Its PubChem CID is 9850038.

CAS No 154357-42-3
Molecular Formula C19H21FN2O4
Molecular Weight 360.40 g/mol
Synonyms (12S)-7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid

Frequently Asked Questions